52-week Open Label Safety-Tolerability Study
NCT07369154
This study is recruiting at 23 US sites in 13 states, according to its ClinicalTrials.gov record last updated .
Summary
Phase 3, open label, multicenter study designed to assess the long term safety and tolerability of LB-102 for the treatment of adult patients with stable schizophrenia
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Schizophrenia
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 3
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- LB Pharmaceuticals Inc.
- Last updated on ClinicalTrials.gov
- September 9, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Arizona · 1
- Chandler Clinical Trials · Chandler, AZ
Arkansas · 3
- Pillar Clinical Research · Bentonville, AR
- Pillar Clinical Research · Little Rock, AR
- Woodland International Research Group · Little Rock, AR
California · 5
- Advanced Research Center · Anaheim, CA
- Synapse Clinical Trials · Cerritos, CA
- CenExel · Culver City, CA
- ProScience Research Group · Culver City, CA
- Synergy San Diego · San Diego, CA
Florida · 3
- CenExel · Hollywood, FL
- Segal Trials · Miami Lakes, FL
- Health Synergy Clinical Research · West Palm Beach, FL
Georgia · 2
- CenExel · Atlanta, GA
- Accelerated Clinical Trial · Snellville, GA
Illinois · 1
- Pillar Clinical Research · Chicago, IL
Maryland · 1
- CenExel Gaithersburg · Gaithersburg, MD
Missouri · 1
- Arch Clinical Trials · St Louis, MO
Nevada · 1
- Redbird Research · Las Vegas, NV
New York · 1
- Neuro-Behavioral Clinical Research · New York, NY
Ohio · 1
- Neuro-Behavioral Clinical Research · Canton, OH
Pennsylvania · 1
- Adams Clinical · Philadelphia, PA
Texas · 2
- Adams Clinical · DeSoto, TX
- Pillar Clinical Research · Richardson, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.